{"text": "Upon examination, presence of intermittent elevated circulating alanine aminotransferase concentration, clinical signs of persistent multiple mitochondrial dna deletions, history of intermittent decreased activity of mitochondrial complex i were noted. Further imaging and laboratory tests identified gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 43, "end": 102, "label": "HPO_term"}, {"start": 133, "end": 169, "label": "HPO_term"}, {"start": 195, "end": 240, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of sudden abnormal cerebral cortex morphology. Laboratory evaluations detected gene variant R853W and G737R. Clinical monitoring is ongoing.", "spans": [{"start": 72, "end": 107, "label": "HPO_term"}]}
{"text": "A medical history of acute abnormal cerebral cortex morphology condition, diagnosed with intermittent decreased activity of mitochondrial complex iv was documented. Genetic analysis confirmed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Supportive care and follow-up were recommended.", "spans": [{"start": 27, "end": 62, "label": "HPO_term"}, {"start": 102, "end": 148, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with episodic elevated circulating aspartate aminotransferase concentration observed. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 111, "label": "HPO_term"}]}
{"text": "A medical history of clinical signs of chronic increased csf lactate was documented. Genetic analysis confirmed gene variant c.2243G>C. Supportive care and follow-up were recommended.", "spans": [{"start": 47, "end": 68, "label": "HPO_term"}]}
{"text": "Initial symptoms included clinical signs of decreased activity of mitochondrial complex i, persistent elevated circulating alanine aminotransferase concentration symptoms, history of acute abnormal cerebral cortex morphology. Subsequent investigations showed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 44, "end": 89, "label": "HPO_term"}, {"start": 102, "end": 161, "label": "HPO_term"}, {"start": 189, "end": 224, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with diagnosed with moderate elevated circulating aspartate aminotransferase concentration, decreased activity of mitochondrial complex i manifestation, history of progressive abnormal cerebral cortex morphology, history of persistent bradykinesia. Diagnostic workup revealed gene variant A467T. Treatment was initiated accordingly.", "spans": [{"start": 65, "end": 126, "label": "HPO_term"}, {"start": 128, "end": 173, "label": "HPO_term"}, {"start": 212, "end": 247, "label": "HPO_term"}, {"start": 271, "end": 283, "label": "HPO_term"}]}
{"text": "Upon examination, history of sudden elevated circulating aspartate aminotransferase concentration, clinical signs of progressive abnormal diffusion weighted cerebral mri morphology, chronic multiple mitochondrial dna deletions were noted. Further imaging and laboratory tests identified gene variant c.2584G>A p.A862T and c.830A>T p.H277L. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 36, "end": 97, "label": "HPO_term"}, {"start": 129, "end": 180, "label": "HPO_term"}, {"start": 190, "end": 226, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with mild elevated circulating aspartate aminotransferase concentration detected. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Treatment was initiated accordingly.", "spans": [{"start": 46, "end": 107, "label": "HPO_term"}]}
{"text": "Initial symptoms included intermittent abnormal diffusion weighted cerebral mri morphology observed, diagnosed with intermittent abnormal cerebral cortex morphology, acute elevated circulating aspartate aminotransferase concentration observed. Subsequent investigations showed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 39, "end": 90, "label": "HPO_term"}, {"start": 129, "end": 164, "label": "HPO_term"}, {"start": 172, "end": 233, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with acute elevated circulating alanine aminotransferase concentration detected. Diagnostic workup revealed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Treatment was initiated accordingly.", "spans": [{"start": 47, "end": 106, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of chronic multiple mitochondrial dna deletions, clinical signs of episodic decreased activity of mitochondrial complex i. Laboratory evaluations detected gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Clinical monitoring is ongoing.", "spans": [{"start": 55, "end": 91, "label": "HPO_term"}, {"start": 120, "end": 165, "label": "HPO_term"}]}
{"text": "A medical history of diagnosed with progressive depletion of mitochondrial dna in muscle tissue, history of episodic elevated circulating aspartate aminotransferase concentration, diagnosed with mild decreased activity of mitochondrial complex i, presence of sudden elevated circulating alanine aminotransferase concentration was documented. Genetic analysis confirmed gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). Supportive care and follow-up were recommended.", "spans": [{"start": 48, "end": 95, "label": "HPO_term"}, {"start": 117, "end": 178, "label": "HPO_term"}, {"start": 200, "end": 245, "label": "HPO_term"}, {"start": 266, "end": 325, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of moderate elevated circulating alanine aminotransferase concentration, episodic elevated circulating aspartate aminotransferase concentration manifestation, mild bradykinesia. Subsequent investigations showed . Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 47, "end": 106, "label": "HPO_term"}, {"start": 117, "end": 178, "label": "HPO_term"}, {"start": 199, "end": 211, "label": "HPO_term"}]}
{"text": "A medical history of persistent abnormal diffusion weighted cerebral mri morphology observed, progressive increased csf lactate condition was documented. Genetic analysis confirmed gene variant W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 32, "end": 83, "label": "HPO_term"}, {"start": 106, "end": 127, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of chronic increased csf lactate, intermittent elevated circulating aspartate aminotransferase concentration detected, diagnosed with depletion of mitochondrial dna in muscle tissue. Laboratory evaluations detected gene variant c.2864A>G (p.Tyr955Cys). Clinical monitoring is ongoing.", "spans": [{"start": 55, "end": 76, "label": "HPO_term"}, {"start": 91, "end": 152, "label": "HPO_term"}, {"start": 178, "end": 225, "label": "HPO_term"}]}
{"text": "Upon examination, intermittent decreased activity of mitochondrial complex i observed, episodic depletion of mitochondrial dna in muscle tissue detected, clinical signs of severe abnormal cerebral cortex morphology, elevated circulating aspartate aminotransferase concentration symptoms were noted. Further imaging and laboratory tests identified gene variant R853W and G737R. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 31, "end": 76, "label": "HPO_term"}, {"start": 96, "end": 143, "label": "HPO_term"}, {"start": 179, "end": 214, "label": "HPO_term"}, {"start": 216, "end": 277, "label": "HPO_term"}]}
{"text": "Upon examination, elevated circulating aspartate aminotransferase concentration observed, acute abnormal diffusion weighted cerebral mri morphology symptoms were noted. Further imaging and laboratory tests identified gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 18, "end": 79, "label": "HPO_term"}, {"start": 96, "end": 147, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of diagnosed with increased csf lactate, severe abnormal cerebral cortex morphology observed. Laboratory evaluations detected gene variant A467T. Clinical monitoring is ongoing.", "spans": [{"start": 62, "end": 83, "label": "HPO_term"}, {"start": 92, "end": 127, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of mild abnormal cerebral cortex morphology symptoms. Laboratory evaluations detected gene variant c.2584G>A p.A862T and c.830A>T p.H277L. Clinical monitoring is ongoing.", "spans": [{"start": 52, "end": 87, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of intermittent abnormal cerebral cortex morphology manifestation, diagnosed with progressive increased csf lactate, presence of multiple mitochondrial dna deletions, presence of acute decreased activity of mitochondrial complex i. Laboratory evaluations detected gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Clinical monitoring is ongoing.", "spans": [{"start": 60, "end": 95, "label": "HPO_term"}, {"start": 138, "end": 159, "label": "HPO_term"}, {"start": 173, "end": 209, "label": "HPO_term"}, {"start": 229, "end": 274, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of elevated circulating aspartate aminotransferase concentration manifestation. Laboratory evaluations detected gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 \u2212 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Clinical monitoring is ongoing.", "spans": [{"start": 47, "end": 108, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of persistent depletion of mitochondrial dna in muscle tissue condition, clinical signs of episodic decreased activity of mitochondrial complex i, diagnosed with acute elevated circulating aspartate aminotransferase concentration. Laboratory evaluations detected gene variant p.Arg953Cys. Clinical monitoring is ongoing.", "spans": [{"start": 58, "end": 105, "label": "HPO_term"}, {"start": 144, "end": 189, "label": "HPO_term"}, {"start": 212, "end": 273, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of decreased activity of mitochondrial complex i detected. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.", "spans": [{"start": 47, "end": 92, "label": "HPO_term"}]}
{"text": "Initial symptoms included clinical signs of acute increased csf lactate, episodic abnormal diffusion weighted cerebral mri morphology symptoms, clinical signs of intermittent elevated circulating aspartate aminotransferase concentration. Subsequent investigations showed . Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 50, "end": 71, "label": "HPO_term"}, {"start": 82, "end": 133, "label": "HPO_term"}, {"start": 175, "end": 236, "label": "HPO_term"}]}
{"text": "A medical history of elevated circulating aspartate aminotransferase concentration observed, acute elevated circulating alanine aminotransferase concentration manifestation, diagnosed with progressive decreased activity of mitochondrial complex i, moderate abnormal diffusion weighted cerebral mri morphology was documented. Genetic analysis confirmed gene variant c.3286C>T (p.Arg1096Cys). Supportive care and follow-up were recommended.", "spans": [{"start": 21, "end": 82, "label": "HPO_term"}, {"start": 99, "end": 158, "label": "HPO_term"}, {"start": 201, "end": 246, "label": "HPO_term"}, {"start": 257, "end": 308, "label": "HPO_term"}]}
{"text": "Upon examination, mild elevated circulating aspartate aminotransferase concentration detected, clinical signs of episodic increased csf lactate, abnormal diffusion weighted cerebral mri morphology condition, presence of moderate elevated circulating alanine aminotransferase concentration were noted. Further imaging and laboratory tests identified gene variant R853W and G737R. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 84, "label": "HPO_term"}, {"start": 122, "end": 143, "label": "HPO_term"}, {"start": 145, "end": 196, "label": "HPO_term"}, {"start": 229, "end": 288, "label": "HPO_term"}]}
{"text": "Upon examination, moderate depletion of mitochondrial dna in muscle tissue observed, presence of severe abnormal cerebral cortex morphology, clinical signs of moderate abnormal diffusion weighted cerebral mri morphology were noted. Further imaging and laboratory tests identified gene variant c.1399G>A (p.A467T) and c.3285C>G (p.S1095R). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 27, "end": 74, "label": "HPO_term"}, {"start": 104, "end": 139, "label": "HPO_term"}, {"start": 168, "end": 219, "label": "HPO_term"}]}
{"text": "Initial symptoms included intermittent multiple mitochondrial dna deletions condition, clinical signs of severe increased csf lactate. Subsequent investigations showed . Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 39, "end": 75, "label": "HPO_term"}, {"start": 112, "end": 133, "label": "HPO_term"}]}
{"text": "Upon examination, progressive depletion of mitochondrial dna in muscle tissue symptoms, presence of episodic abnormal diffusion weighted cerebral mri morphology were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 30, "end": 77, "label": "HPO_term"}, {"start": 109, "end": 160, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of persistent bradykinesia. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Treatment was initiated accordingly.", "spans": [{"start": 63, "end": 75, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of episodic depletion of mitochondrial dna in muscle tissue. Subsequent investigations showed gene variant p.Arg627Gln and p.Arg852Cys. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 47, "end": 94, "label": "HPO_term"}]}
{"text": "Upon examination, chronic bradykinesia detected were noted. Further imaging and laboratory tests identified . The patient was started on a tailored therapeutic plan.", "spans": [{"start": 26, "end": 38, "label": "HPO_term"}]}
{"text": "A medical history of mild decreased activity of mitochondrial complex i condition, mild decreased activity of mitochondrial complex iv observed, intermittent increased csf lactate manifestation, persistent abnormal diffusion weighted cerebral mri morphology was documented. Genetic analysis confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Supportive care and follow-up were recommended.", "spans": [{"start": 26, "end": 71, "label": "HPO_term"}, {"start": 88, "end": 134, "label": "HPO_term"}, {"start": 158, "end": 179, "label": "HPO_term"}, {"start": 206, "end": 257, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of presence of persistent bradykinesia, chronic abnormal cerebral cortex morphology observed. Laboratory evaluations detected gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Clinical monitoring is ongoing.", "spans": [{"start": 70, "end": 82, "label": "HPO_term"}, {"start": 92, "end": 127, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of progressive depletion of mitochondrial dna in muscle tissue, chronic decreased activity of mitochondrial complex i condition, clinical signs of sudden increased csf lactate, progressive elevated circulating alanine aminotransferase concentration condition. Laboratory evaluations detected gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Clinical monitoring is ongoing.", "spans": [{"start": 77, "end": 124, "label": "HPO_term"}, {"start": 134, "end": 179, "label": "HPO_term"}, {"start": 216, "end": 237, "label": "HPO_term"}, {"start": 251, "end": 310, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of presence of progressive abnormal cerebral cortex morphology, acute increased csf lactate, presence of chronic depletion of mitochondrial dna in muscle tissue, presence of sudden elevated circulating alanine aminotransferase concentration. Laboratory evaluations detected gene variant c.2864A>G (p.Tyr955Cys). Clinical monitoring is ongoing.", "spans": [{"start": 71, "end": 106, "label": "HPO_term"}, {"start": 114, "end": 135, "label": "HPO_term"}, {"start": 157, "end": 204, "label": "HPO_term"}, {"start": 225, "end": 284, "label": "HPO_term"}]}
{"text": "A medical history of increased csf lactate observed was documented. Genetic analysis confirmed gene variant c.2243G>C p.Trp748Ser. Supportive care and follow-up were recommended.", "spans": [{"start": 21, "end": 42, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of abnormal cerebral cortex morphology symptoms. Laboratory evaluations detected gene variant P765T. Clinical monitoring is ongoing.", "spans": [{"start": 47, "end": 82, "label": "HPO_term"}]}
{"text": "A medical history of severe decreased activity of mitochondrial complex iv observed, diagnosed with chronic decreased activity of mitochondrial complex i was documented. Genetic analysis confirmed gene variant c.2243G>C p.Trp748Ser. Supportive care and follow-up were recommended.", "spans": [{"start": 28, "end": 74, "label": "HPO_term"}, {"start": 28, "end": 73, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of acute bradykinesia, elevated circulating alanine aminotransferase concentration, intermittent increased csf lactate symptoms were noted. Further imaging and laboratory tests identified gene variant 1399G>A A467T and 3573G>T K1191N. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 42, "end": 54, "label": "HPO_term"}, {"start": 56, "end": 115, "label": "HPO_term"}, {"start": 130, "end": 151, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with episodic elevated circulating aspartate aminotransferase concentration, episodic abnormal cerebral cortex morphology observed, chronic depletion of mitochondrial dna in muscle tissue manifestation, persistent bradykinesia detected. Diagnostic workup revealed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 111, "label": "HPO_term"}, {"start": 122, "end": 157, "label": "HPO_term"}, {"start": 176, "end": 223, "label": "HPO_term"}, {"start": 250, "end": 262, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with chronic abnormal cerebral cortex morphology detected, intermittent decreased activity of mitochondrial complex iv symptoms, presence of acute bradykinesia. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.", "spans": [{"start": 49, "end": 84, "label": "HPO_term"}, {"start": 108, "end": 154, "label": "HPO_term"}, {"start": 183, "end": 195, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of intermittent decreased activity of mitochondrial complex i, clinical signs of persistent elevated circulating aspartate aminotransferase concentration. Laboratory evaluations detected gene variant p.Arg953Cys. Clinical monitoring is ongoing.", "spans": [{"start": 78, "end": 123, "label": "HPO_term"}, {"start": 154, "end": 215, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of intermittent depletion of mitochondrial dna in muscle tissue, sudden decreased activity of mitochondrial complex iv. Laboratory evaluations detected gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Clinical monitoring is ongoing.", "spans": [{"start": 78, "end": 125, "label": "HPO_term"}, {"start": 134, "end": 180, "label": "HPO_term"}]}
{"text": "Upon examination, presence of episodic decreased activity of mitochondrial complex iv, progressive bradykinesia manifestation, progressive decreased activity of mitochondrial complex i observed were noted. Further imaging and laboratory tests identified . The patient was started on a tailored therapeutic plan.", "spans": [{"start": 39, "end": 85, "label": "HPO_term"}, {"start": 99, "end": 111, "label": "HPO_term"}, {"start": 39, "end": 84, "label": "HPO_term"}]}
{"text": "Initial symptoms included diagnosed with progressive decreased activity of mitochondrial complex iv. Subsequent investigations showed gene variant c.1535A>T p.K512M. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 53, "end": 99, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of acute abnormal diffusion weighted cerebral mri morphology. Subsequent investigations showed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 44, "end": 95, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of acute abnormal diffusion weighted cerebral mri morphology condition, episodic elevated circulating aspartate aminotransferase concentration detected. Laboratory evaluations detected gene variant c.2243G>C. Clinical monitoring is ongoing.", "spans": [{"start": 53, "end": 104, "label": "HPO_term"}, {"start": 125, "end": 186, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with diagnosed with mild multiple mitochondrial dna deletions. Diagnostic workup revealed gene variant R853W and G737R. Treatment was initiated accordingly.", "spans": [{"start": 61, "end": 97, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with episodic multiple mitochondrial dna deletions observed. Diagnostic workup revealed . Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 86, "label": "HPO_term"}]}
{"text": "Initial symptoms included history of mild increased csf lactate. Subsequent investigations showed gene variant 1868T>G  L623W and 2263A>G K755E. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 42, "end": 63, "label": "HPO_term"}]}
{"text": "Upon examination, moderate bradykinesia were noted. Further imaging and laboratory tests identified . The patient was started on a tailored therapeutic plan.", "spans": [{"start": 27, "end": 39, "label": "HPO_term"}]}
{"text": "Initial symptoms included bradykinesia symptoms. Subsequent investigations showed gene variant c.1535A>T p.K512M. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 26, "end": 38, "label": "HPO_term"}]}
{"text": "A medical history of history of mild abnormal diffusion weighted cerebral mri morphology was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 37, "end": 88, "label": "HPO_term"}]}
{"text": "Initial symptoms included persistent depletion of mitochondrial dna in muscle tissue observed, diagnosed with progressive abnormal diffusion weighted cerebral mri morphology, severe multiple mitochondrial dna deletions symptoms, presence of sudden decreased activity of mitochondrial complex i. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 37, "end": 84, "label": "HPO_term"}, {"start": 122, "end": 173, "label": "HPO_term"}, {"start": 182, "end": 218, "label": "HPO_term"}, {"start": 248, "end": 293, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of episodic elevated circulating alanine aminotransferase concentration symptoms, clinical signs of acute decreased activity of mitochondrial complex iv. Laboratory evaluations detected gene variant c.679C>T p.R227W and c.2542G>A p.G848S. Clinical monitoring is ongoing.", "spans": [{"start": 56, "end": 115, "label": "HPO_term"}, {"start": 150, "end": 196, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of intermittent bradykinesia detected, episodic elevated circulating aspartate aminotransferase concentration manifestation. Laboratory evaluations detected . Clinical monitoring is ongoing.", "spans": [{"start": 60, "end": 72, "label": "HPO_term"}, {"start": 92, "end": 153, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of chronic abnormal cerebral cortex morphology. Laboratory evaluations detected gene variant R853W and G737R. Clinical monitoring is ongoing.", "spans": [{"start": 55, "end": 90, "label": "HPO_term"}]}
{"text": "Upon examination, severe multiple mitochondrial dna deletions observed, diagnosed with sudden elevated circulating aspartate aminotransferase concentration, mild decreased activity of mitochondrial complex iv observed, diagnosed with intermittent abnormal diffusion weighted cerebral mri morphology were noted. Further imaging and laboratory tests identified gene variant c.1535A>T p.K512M. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 25, "end": 61, "label": "HPO_term"}, {"start": 94, "end": 155, "label": "HPO_term"}, {"start": 162, "end": 208, "label": "HPO_term"}, {"start": 247, "end": 298, "label": "HPO_term"}]}
{"text": "A medical history of diagnosed with mild decreased activity of mitochondrial complex iv, mild elevated circulating aspartate aminotransferase concentration manifestation, clinical signs of persistent abnormal cerebral cortex morphology was documented. Genetic analysis confirmed gene variant 1399G\u2192A (A467T). Supportive care and follow-up were recommended.", "spans": [{"start": 41, "end": 87, "label": "HPO_term"}, {"start": 94, "end": 155, "label": "HPO_term"}, {"start": 200, "end": 235, "label": "HPO_term"}]}
{"text": "A medical history of clinical signs of progressive increased csf lactate, intermittent elevated circulating aspartate aminotransferase concentration symptoms, diagnosed with sudden bradykinesia was documented. Genetic analysis confirmed gene variant c.1399G>A p.Ala467Thr and c.2542G>A p.Gly848Ser. Supportive care and follow-up were recommended.", "spans": [{"start": 51, "end": 72, "label": "HPO_term"}, {"start": 87, "end": 148, "label": "HPO_term"}, {"start": 181, "end": 193, "label": "HPO_term"}]}
{"text": "A medical history of clinical signs of progressive increased csf lactate was documented. Genetic analysis confirmed gene variant C752T (T251I) and C1760T (P587L). Supportive care and follow-up were recommended.", "spans": [{"start": 51, "end": 72, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with moderate abnormal cerebral cortex morphology. Diagnostic workup revealed gene variant c.3286C>T (p.Arg1096Cys). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 85, "label": "HPO_term"}]}
{"text": "A medical history of presence of moderate abnormal cerebral cortex morphology, mild depletion of mitochondrial dna in muscle tissue symptoms was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 42, "end": 77, "label": "HPO_term"}, {"start": 84, "end": 131, "label": "HPO_term"}]}
{"text": "Initial symptoms included moderate decreased activity of mitochondrial complex iv manifestation, moderate abnormal cerebral cortex morphology symptoms. Subsequent investigations showed gene variant W748S. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 35, "end": 81, "label": "HPO_term"}, {"start": 106, "end": 141, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of persistent abnormal cerebral cortex morphology, presence of chronic elevated circulating alanine aminotransferase concentration. Laboratory evaluations detected gene variant c.2243G>C. Clinical monitoring is ongoing.", "spans": [{"start": 58, "end": 93, "label": "HPO_term"}, {"start": 115, "end": 174, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of severe increased csf lactate symptoms, history of decreased activity of mitochondrial complex i, history of chronic depletion of mitochondrial dna in muscle tissue. Laboratory evaluations detected gene variant c.2243G>C p.Trp748Ser. Clinical monitoring is ongoing.", "spans": [{"start": 54, "end": 75, "label": "HPO_term"}, {"start": 97, "end": 142, "label": "HPO_term"}, {"start": 163, "end": 210, "label": "HPO_term"}]}
{"text": "A medical history of acute decreased activity of mitochondrial complex i observed, history of increased csf lactate, intermittent depletion of mitochondrial dna in muscle tissue observed was documented. Genetic analysis confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Supportive care and follow-up were recommended.", "spans": [{"start": 27, "end": 72, "label": "HPO_term"}, {"start": 94, "end": 115, "label": "HPO_term"}, {"start": 130, "end": 177, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with persistent bradykinesia observed, mild abnormal diffusion weighted cerebral mri morphology observed, diagnosed with moderate decreased activity of mitochondrial complex i. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Treatment was initiated accordingly.", "spans": [{"start": 52, "end": 64, "label": "HPO_term"}, {"start": 80, "end": 131, "label": "HPO_term"}, {"start": 166, "end": 211, "label": "HPO_term"}]}
{"text": "Upon examination, episodic abnormal cerebral cortex morphology condition, chronic elevated circulating alanine aminotransferase concentration detected, acute elevated circulating aspartate aminotransferase concentration were noted. Further imaging and laboratory tests identified gene variant p.W748S and p.T914P. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 27, "end": 62, "label": "HPO_term"}, {"start": 82, "end": 141, "label": "HPO_term"}, {"start": 158, "end": 219, "label": "HPO_term"}]}
{"text": "Upon examination, mild abnormal diffusion weighted cerebral mri morphology manifestation were noted. Further imaging and laboratory tests identified gene variant c3239G>C p.Ser1080Thr. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 74, "label": "HPO_term"}]}
{"text": "Initial symptoms included clinical signs of episodic abnormal cerebral cortex morphology, history of progressive elevated circulating alanine aminotransferase concentration, acute abnormal diffusion weighted cerebral mri morphology symptoms. Subsequent investigations showed gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 53, "end": 88, "label": "HPO_term"}, {"start": 113, "end": 172, "label": "HPO_term"}, {"start": 180, "end": 231, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of mild abnormal diffusion weighted cerebral mri morphology. Diagnostic workup revealed gene variant c.3286C>T (p.Arg1096Cys). Treatment was initiated accordingly.", "spans": [{"start": 57, "end": 108, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of progressive decreased activity of mitochondrial complex i observed, clinical signs of progressive depletion of mitochondrial dna in muscle tissue, presence of chronic elevated circulating aspartate aminotransferase concentration, intermittent multiple mitochondrial dna deletions detected. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.", "spans": [{"start": 59, "end": 104, "label": "HPO_term"}, {"start": 145, "end": 192, "label": "HPO_term"}, {"start": 214, "end": 275, "label": "HPO_term"}, {"start": 290, "end": 326, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of history of severe elevated circulating alanine aminotransferase concentration, severe increased csf lactate detected. Laboratory evaluations detected gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Clinical monitoring is ongoing.", "spans": [{"start": 65, "end": 124, "label": "HPO_term"}, {"start": 133, "end": 154, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with episodic elevated circulating alanine aminotransferase concentration manifestation, clinical signs of progressive decreased activity of mitochondrial complex iv, clinical signs of moderate multiple mitochondrial dna deletions. Diagnostic workup revealed gene variant W748S and c.3643+2T>C. Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 109, "label": "HPO_term"}, {"start": 155, "end": 201, "label": "HPO_term"}, {"start": 230, "end": 266, "label": "HPO_term"}]}
{"text": "Upon examination, presence of intermittent elevated circulating alanine aminotransferase concentration, sudden abnormal diffusion weighted cerebral mri morphology manifestation, progressive decreased activity of mitochondrial complex iv condition were noted. Further imaging and laboratory tests identified gene variant 1399G\u2192A (A467T). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 43, "end": 102, "label": "HPO_term"}, {"start": 111, "end": 162, "label": "HPO_term"}, {"start": 190, "end": 236, "label": "HPO_term"}]}
{"text": "Upon examination, acute decreased activity of mitochondrial complex iv manifestation were noted. Further imaging and laboratory tests identified gene variant W748S and c.3643+2T>C. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 24, "end": 70, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of mild increased csf lactate condition. Laboratory evaluations detected gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Clinical monitoring is ongoing.", "spans": [{"start": 52, "end": 73, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of intermittent depletion of mitochondrial dna in muscle tissue. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Treatment was initiated accordingly.", "spans": [{"start": 66, "end": 113, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of sudden increased csf lactate. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 45, "end": 66, "label": "HPO_term"}]}
{"text": "A medical history of persistent bradykinesia symptoms was documented. Genetic analysis confirmed gene variant W748S and c.3643+2T>C. Supportive care and follow-up were recommended.", "spans": [{"start": 32, "end": 44, "label": "HPO_term"}]}
{"text": "A medical history of presence of elevated circulating aspartate aminotransferase concentration, mild abnormal cerebral cortex morphology symptoms, clinical signs of episodic multiple mitochondrial dna deletions was documented. Genetic analysis confirmed gene variant R853W and G737R. Supportive care and follow-up were recommended.", "spans": [{"start": 33, "end": 94, "label": "HPO_term"}, {"start": 101, "end": 136, "label": "HPO_term"}, {"start": 174, "end": 210, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of abnormal diffusion weighted cerebral mri morphology condition, diagnosed with mild decreased activity of mitochondrial complex iv. Laboratory evaluations detected gene variant A467T. Clinical monitoring is ongoing.", "spans": [{"start": 47, "end": 98, "label": "HPO_term"}, {"start": 130, "end": 176, "label": "HPO_term"}]}
{"text": "Upon examination, mild bradykinesia condition, sudden abnormal diffusion weighted cerebral mri morphology were noted. Further imaging and laboratory tests identified gene variant c.1535A>T p.K512M. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 35, "label": "HPO_term"}, {"start": 54, "end": 105, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of chronic abnormal cerebral cortex morphology, presence of persistent depletion of mitochondrial dna in muscle tissue, presence of abnormal diffusion weighted cerebral mri morphology, mild elevated circulating alanine aminotransferase concentration condition. Diagnostic workup revealed gene variant A467T. Treatment was initiated accordingly.", "spans": [{"start": 60, "end": 95, "label": "HPO_term"}, {"start": 120, "end": 167, "label": "HPO_term"}, {"start": 181, "end": 232, "label": "HPO_term"}, {"start": 239, "end": 298, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of persistent elevated circulating alanine aminotransferase concentration, persistent multiple mitochondrial dna deletions manifestation, mild decreased activity of mitochondrial complex iv were noted. Further imaging and laboratory tests identified gene variant c.1288A>T and c.2752T>C. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 47, "end": 106, "label": "HPO_term"}, {"start": 119, "end": 155, "label": "HPO_term"}, {"start": 176, "end": 222, "label": "HPO_term"}]}
{"text": "Initial symptoms included history of chronic elevated circulating aspartate aminotransferase concentration, progressive increased csf lactate manifestation. Subsequent investigations showed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 \u2212 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 45, "end": 106, "label": "HPO_term"}, {"start": 120, "end": 141, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with sudden decreased activity of mitochondrial complex iv symptoms. Diagnostic workup revealed gene variant p.A467T and c.2157+5_6GC>AG. Treatment was initiated accordingly.", "spans": [{"start": 48, "end": 94, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of moderate bradykinesia. Laboratory evaluations detected gene variant p.Arg627Gln and p.Arg852Cys. Clinical monitoring is ongoing.", "spans": [{"start": 56, "end": 68, "label": "HPO_term"}]}
{"text": "Initial symptoms included intermittent depletion of mitochondrial dna in muscle tissue manifestation. Subsequent investigations showed gene variant p.Arg627Gln and p.Arg852Cys. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 39, "end": 86, "label": "HPO_term"}]}
{"text": "A medical history of intermittent decreased activity of mitochondrial complex iv symptoms, history of mild multiple mitochondrial dna deletions, history of moderate depletion of mitochondrial dna in muscle tissue, intermittent elevated circulating alanine aminotransferase concentration was documented. Genetic analysis confirmed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Supportive care and follow-up were recommended.", "spans": [{"start": 34, "end": 80, "label": "HPO_term"}, {"start": 107, "end": 143, "label": "HPO_term"}, {"start": 165, "end": 212, "label": "HPO_term"}, {"start": 227, "end": 286, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of mild elevated circulating alanine aminotransferase concentration, moderate depletion of mitochondrial dna in muscle tissue condition, chronic bradykinesia, episodic multiple mitochondrial dna deletions manifestation. Subsequent investigations showed gene variant c.2554C>T (p.R852C) and c.32G>A (p.G11D). Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 43, "end": 102, "label": "HPO_term"}, {"start": 113, "end": 160, "label": "HPO_term"}, {"start": 180, "end": 192, "label": "HPO_term"}, {"start": 203, "end": 239, "label": "HPO_term"}]}
{"text": "Initial symptoms included multiple mitochondrial dna deletions detected, moderate elevated circulating aspartate aminotransferase concentration observed, episodic elevated circulating alanine aminotransferase concentration condition. Subsequent investigations showed gene variant W748S. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 26, "end": 62, "label": "HPO_term"}, {"start": 82, "end": 143, "label": "HPO_term"}, {"start": 163, "end": 222, "label": "HPO_term"}]}
{"text": "Initial symptoms included moderate abnormal diffusion weighted cerebral mri morphology observed, episodic abnormal cerebral cortex morphology manifestation, acute multiple mitochondrial dna deletions manifestation, moderate decreased activity of mitochondrial complex iv condition. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 35, "end": 86, "label": "HPO_term"}, {"start": 106, "end": 141, "label": "HPO_term"}, {"start": 163, "end": 199, "label": "HPO_term"}, {"start": 224, "end": 270, "label": "HPO_term"}]}
{"text": "A medical history of chronic elevated circulating aspartate aminotransferase concentration condition was documented. Genetic analysis confirmed gene variant c.2993C>T p.998S>L and c.3550G>C p.1184D>H. Supportive care and follow-up were recommended.", "spans": [{"start": 29, "end": 90, "label": "HPO_term"}]}
{"text": "A medical history of acute abnormal diffusion weighted cerebral mri morphology observed, clinical signs of progressive bradykinesia, clinical signs of persistent abnormal cerebral cortex morphology, diagnosed with moderate increased csf lactate was documented. Genetic analysis confirmed gene variant Tyr955Cys. Supportive care and follow-up were recommended.", "spans": [{"start": 27, "end": 78, "label": "HPO_term"}, {"start": 119, "end": 131, "label": "HPO_term"}, {"start": 162, "end": 197, "label": "HPO_term"}, {"start": 223, "end": 244, "label": "HPO_term"}]}
{"text": "Initial symptoms included progressive decreased activity of mitochondrial complex iv detected, chronic abnormal diffusion weighted cerebral mri morphology observed. Subsequent investigations showed gene variant p.Arg627Gln and p.Arg852Cys. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 38, "end": 84, "label": "HPO_term"}, {"start": 103, "end": 154, "label": "HPO_term"}]}
{"text": "A medical history of history of intermittent elevated circulating aspartate aminotransferase concentration, severe abnormal cerebral cortex morphology detected was documented. Genetic analysis confirmed gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. Supportive care and follow-up were recommended.", "spans": [{"start": 45, "end": 106, "label": "HPO_term"}, {"start": 115, "end": 150, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of moderate bradykinesia, history of intermittent abnormal diffusion weighted cerebral mri morphology, intermittent depletion of mitochondrial dna in muscle tissue detected were noted. Further imaging and laboratory tests identified gene variant c.1288A>T p.M430L and c.2752T>C p.W918R. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 45, "end": 57, "label": "HPO_term"}, {"start": 83, "end": 134, "label": "HPO_term"}, {"start": 149, "end": 196, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of moderate decreased activity of mitochondrial complex i, acute multiple mitochondrial dna deletions observed, history of progressive elevated circulating aspartate aminotransferase concentration, presence of intermittent depletion of mitochondrial dna in muscle tissue. Diagnostic workup revealed gene variant P765T. Treatment was initiated accordingly.", "spans": [{"start": 61, "end": 106, "label": "HPO_term"}, {"start": 114, "end": 150, "label": "HPO_term"}, {"start": 184, "end": 245, "label": "HPO_term"}, {"start": 272, "end": 319, "label": "HPO_term"}]}
{"text": "Upon examination, acute bradykinesia condition, presence of acute elevated circulating aspartate aminotransferase concentration, history of mild decreased activity of mitochondrial complex i were noted. Further imaging and laboratory tests identified gene variant c.3311C>G (p.S1104C) and c.2542G>A (p.G848S). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 24, "end": 36, "label": "HPO_term"}, {"start": 66, "end": 127, "label": "HPO_term"}, {"start": 145, "end": 190, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of progressive abnormal cerebral cortex morphology. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.", "spans": [{"start": 77, "end": 112, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with persistent decreased activity of mitochondrial complex i condition. Diagnostic workup revealed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Treatment was initiated accordingly.", "spans": [{"start": 52, "end": 97, "label": "HPO_term"}]}
{"text": "Initial symptoms included chronic abnormal diffusion weighted cerebral mri morphology manifestation, history of moderate depletion of mitochondrial dna in muscle tissue, clinical signs of moderate abnormal cerebral cortex morphology, chronic decreased activity of mitochondrial complex i symptoms. Subsequent investigations showed gene variant 1868T>G  L623W and 2263A>G K755E. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 34, "end": 85, "label": "HPO_term"}, {"start": 121, "end": 168, "label": "HPO_term"}, {"start": 197, "end": 232, "label": "HPO_term"}, {"start": 242, "end": 287, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of persistent elevated circulating aspartate aminotransferase concentration, severe abnormal diffusion weighted cerebral mri morphology observed were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 47, "end": 108, "label": "HPO_term"}, {"start": 117, "end": 168, "label": "HPO_term"}]}
{"text": "Upon examination, chronic abnormal cerebral cortex morphology manifestation, diagnosed with acute decreased activity of mitochondrial complex iv were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 26, "end": 61, "label": "HPO_term"}, {"start": 98, "end": 144, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of history of intermittent decreased activity of mitochondrial complex iv, abnormal diffusion weighted cerebral mri morphology condition, clinical signs of severe multiple mitochondrial dna deletions. Laboratory evaluations detected gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Clinical monitoring is ongoing.", "spans": [{"start": 71, "end": 117, "label": "HPO_term"}, {"start": 119, "end": 170, "label": "HPO_term"}, {"start": 207, "end": 243, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with persistent abnormal cerebral cortex morphology detected, sudden bradykinesia symptoms, severe multiple mitochondrial dna deletions manifestation, mild increased csf lactate observed. Diagnostic workup revealed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Treatment was initiated accordingly.", "spans": [{"start": 52, "end": 87, "label": "HPO_term"}, {"start": 105, "end": 117, "label": "HPO_term"}, {"start": 135, "end": 171, "label": "HPO_term"}, {"start": 192, "end": 213, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of persistent elevated circulating aspartate aminotransferase concentration. Diagnostic workup revealed gene variant R853W and G737R. Treatment was initiated accordingly.", "spans": [{"start": 63, "end": 124, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of persistent decreased activity of mitochondrial complex iv. Diagnostic workup revealed gene variant R853W and G737R. Treatment was initiated accordingly.", "spans": [{"start": 64, "end": 110, "label": "HPO_term"}]}
{"text": "Upon examination, episodic decreased activity of mitochondrial complex iv symptoms, severe elevated circulating alanine aminotransferase concentration manifestation, history of moderate multiple mitochondrial dna deletions were noted. Further imaging and laboratory tests identified gene variant A467T. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 27, "end": 73, "label": "HPO_term"}, {"start": 91, "end": 150, "label": "HPO_term"}, {"start": 186, "end": 222, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of intermittent elevated circulating aspartate aminotransferase concentration, chronic increased csf lactate detected. Laboratory evaluations detected gene variant p.Arg627Gln and p.Arg852Cys. Clinical monitoring is ongoing.", "spans": [{"start": 60, "end": 121, "label": "HPO_term"}, {"start": 131, "end": 152, "label": "HPO_term"}]}
{"text": "Initial symptoms included severe decreased activity of mitochondrial complex i manifestation. Subsequent investigations showed gene variant A467T and W748S. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 33, "end": 78, "label": "HPO_term"}]}
{"text": "Initial symptoms included history of chronic elevated circulating alanine aminotransferase concentration. Subsequent investigations showed gene variant A467T and W748S. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 45, "end": 104, "label": "HPO_term"}]}
{"text": "Initial symptoms included clinical signs of increased csf lactate, clinical signs of severe abnormal cerebral cortex morphology, moderate decreased activity of mitochondrial complex i detected, diagnosed with mild elevated circulating alanine aminotransferase concentration. Subsequent investigations showed gene variant R853W and G737R. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 44, "end": 65, "label": "HPO_term"}, {"start": 92, "end": 127, "label": "HPO_term"}, {"start": 138, "end": 183, "label": "HPO_term"}, {"start": 214, "end": 273, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of chronic decreased activity of mitochondrial complex i condition. Laboratory evaluations detected gene variant T251I/P587L and R807C. Clinical monitoring is ongoing.", "spans": [{"start": 55, "end": 100, "label": "HPO_term"}]}
{"text": "A medical history of depletion of mitochondrial dna in muscle tissue symptoms, persistent elevated circulating aspartate aminotransferase concentration symptoms, intermittent increased csf lactate detected was documented. Genetic analysis confirmed gene variant c.1535A>T p.K512M. Supportive care and follow-up were recommended.", "spans": [{"start": 21, "end": 68, "label": "HPO_term"}, {"start": 90, "end": 151, "label": "HPO_term"}, {"start": 175, "end": 196, "label": "HPO_term"}]}
{"text": "Initial symptoms included abnormal diffusion weighted cerebral mri morphology manifestation, diagnosed with episodic depletion of mitochondrial dna in muscle tissue, episodic decreased activity of mitochondrial complex iv detected. Subsequent investigations showed gene variant p.W748S and p.T914P. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 26, "end": 77, "label": "HPO_term"}, {"start": 117, "end": 164, "label": "HPO_term"}, {"start": 175, "end": 221, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of sudden multiple mitochondrial dna deletions condition, diagnosed with persistent elevated circulating aspartate aminotransferase concentration, moderate decreased activity of mitochondrial complex iv observed. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.", "spans": [{"start": 54, "end": 90, "label": "HPO_term"}, {"start": 128, "end": 189, "label": "HPO_term"}, {"start": 200, "end": 246, "label": "HPO_term"}]}
{"text": "Initial symptoms included acute depletion of mitochondrial dna in muscle tissue detected, diagnosed with progressive decreased activity of mitochondrial complex i, diagnosed with chronic increased csf lactate. Subsequent investigations showed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 32, "end": 79, "label": "HPO_term"}, {"start": 117, "end": 162, "label": "HPO_term"}, {"start": 187, "end": 208, "label": "HPO_term"}]}
{"text": "Upon examination, intermittent depletion of mitochondrial dna in muscle tissue observed, sudden multiple mitochondrial dna deletions condition, acute decreased activity of mitochondrial complex iv condition, increased csf lactate condition were noted. Further imaging and laboratory tests identified gene variant 1868T>G  L623W and 2263A>G K755E. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 31, "end": 78, "label": "HPO_term"}, {"start": 96, "end": 132, "label": "HPO_term"}, {"start": 150, "end": 196, "label": "HPO_term"}, {"start": 208, "end": 229, "label": "HPO_term"}]}
{"text": "A medical history of mild abnormal cerebral cortex morphology observed, progressive decreased activity of mitochondrial complex i condition, severe decreased activity of mitochondrial complex iv detected was documented. Genetic analysis confirmed gene variant Tyr955Cys. Supportive care and follow-up were recommended.", "spans": [{"start": 26, "end": 61, "label": "HPO_term"}, {"start": 84, "end": 129, "label": "HPO_term"}, {"start": 148, "end": 194, "label": "HPO_term"}]}
{"text": "A medical history of episodic multiple mitochondrial dna deletions observed, presence of chronic decreased activity of mitochondrial complex iv, intermittent abnormal diffusion weighted cerebral mri morphology symptoms, diagnosed with acute abnormal cerebral cortex morphology was documented. Genetic analysis confirmed gene variant A467T. Supportive care and follow-up were recommended.", "spans": [{"start": 30, "end": 66, "label": "HPO_term"}, {"start": 97, "end": 143, "label": "HPO_term"}, {"start": 158, "end": 209, "label": "HPO_term"}, {"start": 241, "end": 276, "label": "HPO_term"}]}
{"text": "A medical history of history of moderate decreased activity of mitochondrial complex i, acute decreased activity of mitochondrial complex iv, moderate bradykinesia symptoms was documented. Genetic analysis confirmed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Supportive care and follow-up were recommended.", "spans": [{"start": 41, "end": 86, "label": "HPO_term"}, {"start": 94, "end": 140, "label": "HPO_term"}, {"start": 151, "end": 163, "label": "HPO_term"}]}
{"text": "Initial symptoms included multiple mitochondrial dna deletions condition, intermittent elevated circulating alanine aminotransferase concentration observed. Subsequent investigations showed gene variant W748S. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 26, "end": 62, "label": "HPO_term"}, {"start": 87, "end": 146, "label": "HPO_term"}]}
{"text": "Upon examination, presence of moderate abnormal cerebral cortex morphology, clinical signs of moderate abnormal diffusion weighted cerebral mri morphology, chronic multiple mitochondrial dna deletions manifestation, diagnosed with moderate elevated circulating aspartate aminotransferase concentration were noted. Further imaging and laboratory tests identified gene variant c.1535A>T p.K512M. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 39, "end": 74, "label": "HPO_term"}, {"start": 103, "end": 154, "label": "HPO_term"}, {"start": 164, "end": 200, "label": "HPO_term"}, {"start": 240, "end": 301, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of persistent depletion of mitochondrial dna in muscle tissue observed, moderate decreased activity of mitochondrial complex i. Laboratory evaluations detected gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Clinical monitoring is ongoing.", "spans": [{"start": 58, "end": 105, "label": "HPO_term"}, {"start": 125, "end": 170, "label": "HPO_term"}]}
{"text": "Upon examination, presence of persistent decreased activity of mitochondrial complex i were noted. Further imaging and laboratory tests identified gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 41, "end": 86, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with moderate decreased activity of mitochondrial complex iv observed, history of sudden abnormal cerebral cortex morphology, elevated circulating aspartate aminotransferase concentration observed. Diagnostic workup revealed gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 96, "label": "HPO_term"}, {"start": 125, "end": 160, "label": "HPO_term"}, {"start": 162, "end": 223, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of persistent increased csf lactate, intermittent elevated circulating aspartate aminotransferase concentration condition, acute decreased activity of mitochondrial complex i condition, decreased activity of mitochondrial complex iv condition. Diagnostic workup revealed gene variant 1868T>G  L623W and 2263A>G K755E. Treatment was initiated accordingly.", "spans": [{"start": 64, "end": 85, "label": "HPO_term"}, {"start": 100, "end": 161, "label": "HPO_term"}, {"start": 179, "end": 224, "label": "HPO_term"}, {"start": 236, "end": 282, "label": "HPO_term"}]}
{"text": "Upon examination, progressive bradykinesia condition, presence of episodic abnormal diffusion weighted cerebral mri morphology, episodic decreased activity of mitochondrial complex iv symptoms, mild elevated circulating alanine aminotransferase concentration symptoms were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 30, "end": 42, "label": "HPO_term"}, {"start": 75, "end": 126, "label": "HPO_term"}, {"start": 137, "end": 183, "label": "HPO_term"}, {"start": 199, "end": 258, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with diagnosed with progressive decreased activity of mitochondrial complex iv, diagnosed with moderate increased csf lactate, history of mild depletion of mitochondrial dna in muscle tissue. Diagnostic workup revealed gene variant W748S. Treatment was initiated accordingly.", "spans": [{"start": 68, "end": 114, "label": "HPO_term"}, {"start": 140, "end": 161, "label": "HPO_term"}, {"start": 179, "end": 226, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of severe bradykinesia, diagnosed with chronic decreased activity of mitochondrial complex i. Laboratory evaluations detected gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Clinical monitoring is ongoing.", "spans": [{"start": 54, "end": 66, "label": "HPO_term"}, {"start": 91, "end": 136, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of moderate multiple mitochondrial dna deletions. Diagnostic workup revealed gene variant R853W and G737R. Treatment was initiated accordingly.", "spans": [{"start": 62, "end": 98, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of persistent increased csf lactate were noted. Further imaging and laboratory tests identified gene variant c. 2243G>C (p. W748S). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 47, "end": 68, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of moderate decreased activity of mitochondrial complex iv, sudden abnormal diffusion weighted cerebral mri morphology. Diagnostic workup revealed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Treatment was initiated accordingly.", "spans": [{"start": 62, "end": 108, "label": "HPO_term"}, {"start": 117, "end": 168, "label": "HPO_term"}]}
{"text": "A medical history of episodic depletion of mitochondrial dna in muscle tissue observed, episodic elevated circulating alanine aminotransferase concentration observed, chronic bradykinesia observed was documented. Genetic analysis confirmed gene variant 1399G>A A467T and 3573G>T K1191N. Supportive care and follow-up were recommended.", "spans": [{"start": 30, "end": 77, "label": "HPO_term"}, {"start": 97, "end": 156, "label": "HPO_term"}, {"start": 175, "end": 187, "label": "HPO_term"}]}
{"text": "A medical history of clinical signs of persistent multiple mitochondrial dna deletions, moderate depletion of mitochondrial dna in muscle tissue, moderate decreased activity of mitochondrial complex iv detected was documented. Genetic analysis confirmed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Supportive care and follow-up were recommended.", "spans": [{"start": 50, "end": 86, "label": "HPO_term"}, {"start": 97, "end": 144, "label": "HPO_term"}, {"start": 155, "end": 201, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of intermittent bradykinesia observed, moderate decreased activity of mitochondrial complex i condition, diagnosed with acute depletion of mitochondrial dna in muscle tissue. Laboratory evaluations detected gene variant 1868T>G  L623W and 2263A>G K755E. Clinical monitoring is ongoing.", "spans": [{"start": 60, "end": 72, "label": "HPO_term"}, {"start": 92, "end": 137, "label": "HPO_term"}, {"start": 170, "end": 217, "label": "HPO_term"}]}
{"text": "A medical history of presence of persistent elevated circulating aspartate aminotransferase concentration, episodic decreased activity of mitochondrial complex iv detected, moderate elevated circulating alanine aminotransferase concentration condition was documented. Genetic analysis confirmed gene variant c.3643+1G>A and c.2396C>A (p.S799Y). Supportive care and follow-up were recommended.", "spans": [{"start": 44, "end": 105, "label": "HPO_term"}, {"start": 116, "end": 162, "label": "HPO_term"}, {"start": 182, "end": 241, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with severe abnormal cerebral cortex morphology detected. Diagnostic workup revealed gene variant c3239G>C p.Ser1080Thr. Treatment was initiated accordingly.", "spans": [{"start": 48, "end": 83, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with history of acute abnormal cerebral cortex morphology, intermittent abnormal diffusion weighted cerebral mri morphology condition, mild depletion of mitochondrial dna in muscle tissue detected. Diagnostic workup revealed gene variant c3239G>C p.Ser1080Thr. Treatment was initiated accordingly.", "spans": [{"start": 58, "end": 93, "label": "HPO_term"}, {"start": 108, "end": 159, "label": "HPO_term"}, {"start": 176, "end": 223, "label": "HPO_term"}]}
{"text": "Upon examination, mild multiple mitochondrial dna deletions, acute bradykinesia, clinical signs of acute abnormal diffusion weighted cerebral mri morphology, episodic elevated circulating alanine aminotransferase concentration were noted. Further imaging and laboratory tests identified gene variant c911T > G (p. L304R) and 3240-3242 duplication (pR1081dup). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 59, "label": "HPO_term"}, {"start": 67, "end": 79, "label": "HPO_term"}, {"start": 105, "end": 156, "label": "HPO_term"}, {"start": 167, "end": 226, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of acute multiple mitochondrial dna deletions, mild abnormal diffusion weighted cerebral mri morphology detected were noted. Further imaging and laboratory tests identified gene variant R853W and G737R. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 42, "end": 78, "label": "HPO_term"}, {"start": 85, "end": 136, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with severe decreased activity of mitochondrial complex i manifestation, depletion of mitochondrial dna in muscle tissue condition. Diagnostic workup revealed gene variant c.1288A>T and c.2752T>C. Treatment was initiated accordingly.", "spans": [{"start": 48, "end": 93, "label": "HPO_term"}, {"start": 109, "end": 156, "label": "HPO_term"}]}
{"text": "A medical history of presence of acute depletion of mitochondrial dna in muscle tissue, sudden elevated circulating alanine aminotransferase concentration observed was documented. Genetic analysis confirmed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Supportive care and follow-up were recommended.", "spans": [{"start": 39, "end": 86, "label": "HPO_term"}, {"start": 95, "end": 154, "label": "HPO_term"}]}
{"text": "A medical history of severe depletion of mitochondrial dna in muscle tissue, persistent decreased activity of mitochondrial complex i detected, acute abnormal cerebral cortex morphology condition was documented. Genetic analysis confirmed gene variant W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 28, "end": 75, "label": "HPO_term"}, {"start": 88, "end": 133, "label": "HPO_term"}, {"start": 150, "end": 185, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of moderate decreased activity of mitochondrial complex i condition. Laboratory evaluations detected . Clinical monitoring is ongoing.", "spans": [{"start": 56, "end": 101, "label": "HPO_term"}]}
{"text": "Upon examination, acute multiple mitochondrial dna deletions, acute decreased activity of mitochondrial complex i condition were noted. Further imaging and laboratory tests identified gene variant c. 2243G>C (p. W748S). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 24, "end": 60, "label": "HPO_term"}, {"start": 68, "end": 113, "label": "HPO_term"}]}
{"text": "A medical history of episodic multiple mitochondrial dna deletions, persistent bradykinesia symptoms, presence of persistent decreased activity of mitochondrial complex i was documented. Genetic analysis confirmed gene variant C752T (T251I) and C1760T (P587L). Supportive care and follow-up were recommended.", "spans": [{"start": 30, "end": 66, "label": "HPO_term"}, {"start": 79, "end": 91, "label": "HPO_term"}, {"start": 125, "end": 170, "label": "HPO_term"}]}
{"text": "A medical history of acute elevated circulating alanine aminotransferase concentration symptoms, abnormal cerebral cortex morphology manifestation, acute increased csf lactate symptoms, history of progressive multiple mitochondrial dna deletions was documented. Genetic analysis confirmed gene variant 1399G>A A467T and 3573G>T K1191N. Supportive care and follow-up were recommended.", "spans": [{"start": 27, "end": 86, "label": "HPO_term"}, {"start": 97, "end": 132, "label": "HPO_term"}, {"start": 154, "end": 175, "label": "HPO_term"}, {"start": 209, "end": 245, "label": "HPO_term"}]}
{"text": "A medical history of presence of chronic abnormal diffusion weighted cerebral mri morphology, persistent multiple mitochondrial dna deletions symptoms was documented. Genetic analysis confirmed gene variant p.A467T (c.1399G>A) and 4740 bp deletion (87,662,161 to 87,666,900 or c.2426 + 77 to c.3483 \u2212 390) in the long arm of chromosome 15, spanning intron 14 to intron 21 of the POLG gene. Supportive care and follow-up were recommended.", "spans": [{"start": 41, "end": 92, "label": "HPO_term"}, {"start": 105, "end": 141, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with elevated circulating alanine aminotransferase concentration, diagnosed with intermittent abnormal cerebral cortex morphology, severe increased csf lactate observed. Diagnostic workup revealed gene variant c.1288A>T and c.2752T>C. Treatment was initiated accordingly.", "spans": [{"start": 41, "end": 100, "label": "HPO_term"}, {"start": 130, "end": 165, "label": "HPO_term"}, {"start": 174, "end": 195, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with moderate decreased activity of mitochondrial complex i, progressive elevated circulating aspartate aminotransferase concentration symptoms. Diagnostic workup revealed gene variant c.752C>T (p.Thr251Ile) and c.1760C>T (p.Pro587Leu). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 95, "label": "HPO_term"}, {"start": 109, "end": 170, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of clinical signs of intermittent abnormal cerebral cortex morphology, mild bradykinesia manifestation, clinical signs of intermittent decreased activity of mitochondrial complex i. Laboratory evaluations detected . Clinical monitoring is ongoing.", "spans": [{"start": 78, "end": 113, "label": "HPO_term"}, {"start": 120, "end": 132, "label": "HPO_term"}, {"start": 179, "end": 224, "label": "HPO_term"}]}
{"text": "A medical history of acute multiple mitochondrial dna deletions symptoms was documented. Genetic analysis confirmed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Supportive care and follow-up were recommended.", "spans": [{"start": 27, "end": 63, "label": "HPO_term"}]}
{"text": "A medical history of diagnosed with mild abnormal diffusion weighted cerebral mri morphology, episodic decreased activity of mitochondrial complex i condition, acute elevated circulating aspartate aminotransferase concentration symptoms, clinical signs of episodic elevated circulating alanine aminotransferase concentration was documented. Genetic analysis confirmed gene variant A467T and W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 41, "end": 92, "label": "HPO_term"}, {"start": 103, "end": 148, "label": "HPO_term"}, {"start": 166, "end": 227, "label": "HPO_term"}, {"start": 265, "end": 324, "label": "HPO_term"}]}
{"text": "Initial symptoms included presence of mild decreased activity of mitochondrial complex iv, diagnosed with acute decreased activity of mitochondrial complex i. Subsequent investigations showed gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 43, "end": 89, "label": "HPO_term"}, {"start": 43, "end": 88, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of chronic elevated circulating alanine aminotransferase concentration detected, mild decreased activity of mitochondrial complex iv observed, history of increased csf lactate. Laboratory evaluations detected gene variant A467T and W748S. Clinical monitoring is ongoing.", "spans": [{"start": 55, "end": 114, "label": "HPO_term"}, {"start": 130, "end": 176, "label": "HPO_term"}, {"start": 198, "end": 219, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with sudden elevated circulating aspartate aminotransferase concentration, chronic depletion of mitochondrial dna in muscle tissue condition, history of abnormal cerebral cortex morphology, elevated circulating alanine aminotransferase concentration condition. Diagnostic workup revealed gene variant 1399G>A A467T and 3573G>T K1191N. Treatment was initiated accordingly.", "spans": [{"start": 48, "end": 109, "label": "HPO_term"}, {"start": 119, "end": 166, "label": "HPO_term"}, {"start": 189, "end": 224, "label": "HPO_term"}, {"start": 226, "end": 285, "label": "HPO_term"}]}
{"text": "Initial symptoms included diagnosed with progressive bradykinesia, diagnosed with moderate abnormal diffusion weighted cerebral mri morphology. Subsequent investigations showed gene variant c.2243G>C p.Trp748Ser. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 53, "end": 65, "label": "HPO_term"}, {"start": 91, "end": 142, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with moderate increased csf lactate detected, chronic decreased activity of mitochondrial complex i detected, clinical signs of episodic multiple mitochondrial dna deletions. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.2542G>A (p.G848S). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 71, "label": "HPO_term"}, {"start": 90, "end": 135, "label": "HPO_term"}, {"start": 173, "end": 209, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with presence of progressive increased csf lactate, moderate multiple mitochondrial dna deletions condition, progressive decreased activity of mitochondrial complex i symptoms. Diagnostic workup revealed gene variant c.1535A>T p.K512M. Treatment was initiated accordingly.", "spans": [{"start": 65, "end": 86, "label": "HPO_term"}, {"start": 97, "end": 133, "label": "HPO_term"}, {"start": 157, "end": 202, "label": "HPO_term"}]}
{"text": "Upon examination, chronic decreased activity of mitochondrial complex iv condition, severe elevated circulating aspartate aminotransferase concentration manifestation, chronic depletion of mitochondrial dna in muscle tissue condition were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 26, "end": 72, "label": "HPO_term"}, {"start": 91, "end": 152, "label": "HPO_term"}, {"start": 176, "end": 223, "label": "HPO_term"}]}
{"text": "Upon examination, acute decreased activity of mitochondrial complex i, presence of persistent elevated circulating aspartate aminotransferase concentration, diagnosed with severe abnormal diffusion weighted cerebral mri morphology were noted. Further imaging and laboratory tests identified gene variant c. 2243G>C (p. W748S). The patient was started on a tailored therapeutic plan.", "spans": [{"start": 24, "end": 69, "label": "HPO_term"}, {"start": 94, "end": 155, "label": "HPO_term"}, {"start": 179, "end": 230, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with sudden increased csf lactate, clinical signs of abnormal cerebral cortex morphology, severe abnormal diffusion weighted cerebral mri morphology, acute multiple mitochondrial dna deletions condition. Diagnostic workup revealed gene variant c.2243G>C. Treatment was initiated accordingly.", "spans": [{"start": 48, "end": 69, "label": "HPO_term"}, {"start": 89, "end": 124, "label": "HPO_term"}, {"start": 133, "end": 184, "label": "HPO_term"}, {"start": 192, "end": 228, "label": "HPO_term"}]}
{"text": "A medical history of mild decreased activity of mitochondrial complex i manifestation was documented. Genetic analysis confirmed . Supportive care and follow-up were recommended.", "spans": [{"start": 26, "end": 71, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of history of acute elevated circulating aspartate aminotransferase concentration, diagnosed with chronic elevated circulating alanine aminotransferase concentration. Laboratory evaluations detected gene variant p.Arg627Gln and p.Arg852Cys. Clinical monitoring is ongoing.", "spans": [{"start": 64, "end": 125, "label": "HPO_term"}, {"start": 150, "end": 209, "label": "HPO_term"}]}
{"text": "Initial symptoms included chronic abnormal diffusion weighted cerebral mri morphology observed, moderate decreased activity of mitochondrial complex i manifestation, depletion of mitochondrial dna in muscle tissue detected. Subsequent investigations showed gene variant c.2243G>C p.Trp748Ser. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 34, "end": 85, "label": "HPO_term"}, {"start": 105, "end": 150, "label": "HPO_term"}, {"start": 166, "end": 213, "label": "HPO_term"}]}
{"text": "Upon examination, intermittent decreased activity of mitochondrial complex iv manifestation, abnormal diffusion weighted cerebral mri morphology condition, sudden elevated circulating alanine aminotransferase concentration, chronic increased csf lactate manifestation were noted. Further imaging and laboratory tests identified gene variant c.1399G>A p.Ala467Thr and c.3626_3629dupGATA. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 31, "end": 77, "label": "HPO_term"}, {"start": 93, "end": 144, "label": "HPO_term"}, {"start": 163, "end": 222, "label": "HPO_term"}, {"start": 232, "end": 253, "label": "HPO_term"}]}
{"text": "A medical history of mild abnormal cerebral cortex morphology, chronic elevated circulating aspartate aminotransferase concentration, clinical signs of progressive abnormal diffusion weighted cerebral mri morphology was documented. Genetic analysis confirmed gene variant 1399G >A A467T and 2243G >C W748S. Supportive care and follow-up were recommended.", "spans": [{"start": 26, "end": 61, "label": "HPO_term"}, {"start": 71, "end": 132, "label": "HPO_term"}, {"start": 164, "end": 215, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of episodic abnormal diffusion weighted cerebral mri morphology symptoms. Laboratory evaluations detected gene variant c.3286C>T (p.Arg1096Cys). Clinical monitoring is ongoing.", "spans": [{"start": 56, "end": 107, "label": "HPO_term"}]}
{"text": "Upon examination, diagnosed with progressive abnormal diffusion weighted cerebral mri morphology, episodic decreased activity of mitochondrial complex iv manifestation, history of chronic multiple mitochondrial dna deletions, sudden decreased activity of mitochondrial complex i were noted. Further imaging and laboratory tests identified gene variant P765T. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 45, "end": 96, "label": "HPO_term"}, {"start": 107, "end": 153, "label": "HPO_term"}, {"start": 188, "end": 224, "label": "HPO_term"}, {"start": 107, "end": 152, "label": "HPO_term"}]}
{"text": "Upon examination, progressive decreased activity of mitochondrial complex i symptoms, bradykinesia observed, presence of acute depletion of mitochondrial dna in muscle tissue, persistent elevated circulating alanine aminotransferase concentration observed were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 30, "end": 75, "label": "HPO_term"}, {"start": 86, "end": 98, "label": "HPO_term"}, {"start": 127, "end": 174, "label": "HPO_term"}, {"start": 187, "end": 246, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of moderate elevated circulating alanine aminotransferase concentration condition. Laboratory evaluations detected gene variant 1399G\u2192A (A467T). Clinical monitoring is ongoing.", "spans": [{"start": 56, "end": 115, "label": "HPO_term"}]}
{"text": "Initial symptoms included abnormal cerebral cortex morphology manifestation, episodic depletion of mitochondrial dna in muscle tissue, diagnosed with elevated circulating alanine aminotransferase concentration. Subsequent investigations showed gene variant A467T. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 26, "end": 61, "label": "HPO_term"}, {"start": 86, "end": 133, "label": "HPO_term"}, {"start": 150, "end": 209, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with progressive elevated circulating alanine aminotransferase concentration observed, severe multiple mitochondrial dna deletions symptoms. Diagnostic workup revealed gene variant c.752C>T (p.T251I) and c.3572A>G (p.K1191R). Treatment was initiated accordingly.", "spans": [{"start": 53, "end": 112, "label": "HPO_term"}, {"start": 130, "end": 166, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with clinical signs of chronic decreased activity of mitochondrial complex i, intermittent decreased activity of mitochondrial complex iv condition. Diagnostic workup revealed gene variant P765T. Treatment was initiated accordingly.", "spans": [{"start": 67, "end": 112, "label": "HPO_term"}, {"start": 127, "end": 173, "label": "HPO_term"}]}
{"text": "Upon examination, mild depletion of mitochondrial dna in muscle tissue detected, persistent abnormal diffusion weighted cerebral mri morphology condition were noted. Further imaging and laboratory tests identified gene variant W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 70, "label": "HPO_term"}, {"start": 92, "end": 143, "label": "HPO_term"}]}
{"text": "Initial symptoms included progressive elevated circulating aspartate aminotransferase concentration condition. Subsequent investigations showed gene variant p.Arg1096His (c.3287G>A) and p.Arg953Cys (c.2857C>T). Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 38, "end": 99, "label": "HPO_term"}]}
{"text": "Initial symptoms included history of elevated circulating aspartate aminotransferase concentration. Subsequent investigations showed gene variant 1399G\u2192A (A467T). Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 37, "end": 98, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with clinical signs of intermittent bradykinesia, intermittent decreased activity of mitochondrial complex i symptoms, progressive depletion of mitochondrial dna in muscle tissue condition. Diagnostic workup revealed gene variant c.2243G>C. Treatment was initiated accordingly.", "spans": [{"start": 72, "end": 84, "label": "HPO_term"}, {"start": 99, "end": 144, "label": "HPO_term"}, {"start": 167, "end": 214, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with chronic abnormal cerebral cortex morphology manifestation, presence of moderate abnormal diffusion weighted cerebral mri morphology. Diagnostic workup revealed . Treatment was initiated accordingly.", "spans": [{"start": 49, "end": 84, "label": "HPO_term"}, {"start": 121, "end": 172, "label": "HPO_term"}]}
{"text": "A medical history of episodic bradykinesia symptoms, episodic abnormal cerebral cortex morphology, moderate depletion of mitochondrial dna in muscle tissue detected, presence of moderate increased csf lactate was documented. Genetic analysis confirmed gene variant p.Arg627Gln and p.Arg852Cys. Supportive care and follow-up were recommended.", "spans": [{"start": 30, "end": 42, "label": "HPO_term"}, {"start": 62, "end": 97, "label": "HPO_term"}, {"start": 108, "end": 155, "label": "HPO_term"}, {"start": 187, "end": 208, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of severe depletion of mitochondrial dna in muscle tissue, presence of severe abnormal cerebral cortex morphology, severe elevated circulating alanine aminotransferase concentration symptoms. Laboratory evaluations detected gene variant 1399G\u2192A (A467T). Clinical monitoring is ongoing.", "spans": [{"start": 54, "end": 101, "label": "HPO_term"}, {"start": 122, "end": 157, "label": "HPO_term"}, {"start": 166, "end": 225, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of severe decreased activity of mitochondrial complex iv symptoms, persistent multiple mitochondrial dna deletions condition, progressive elevated circulating alanine aminotransferase concentration manifestation. Laboratory evaluations detected gene variant W748S and 15q26 118 kb deletion involving POLG1 gene and FANCI gene. Clinical monitoring is ongoing.", "spans": [{"start": 54, "end": 100, "label": "HPO_term"}, {"start": 122, "end": 158, "label": "HPO_term"}, {"start": 182, "end": 241, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with multiple mitochondrial dna deletions symptoms. Diagnostic workup revealed gene variant T251I/P587L and R807C. Treatment was initiated accordingly.", "spans": [{"start": 41, "end": 77, "label": "HPO_term"}]}
{"text": "The individual was admitted with complaints of presence of decreased activity of mitochondrial complex i, decreased activity of mitochondrial complex iv condition. Laboratory evaluations detected gene variant p.W748S and p.T914P. Clinical monitoring is ongoing.", "spans": [{"start": 59, "end": 104, "label": "HPO_term"}, {"start": 106, "end": 152, "label": "HPO_term"}]}
{"text": "A medical history of sudden decreased activity of mitochondrial complex iv symptoms, severe abnormal cerebral cortex morphology condition, persistent multiple mitochondrial dna deletions detected was documented. Genetic analysis confirmed gene variant R853W and G737R. Supportive care and follow-up were recommended.", "spans": [{"start": 28, "end": 74, "label": "HPO_term"}, {"start": 92, "end": 127, "label": "HPO_term"}, {"start": 150, "end": 186, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with acute decreased activity of mitochondrial complex i detected, history of sudden increased csf lactate. Diagnostic workup revealed gene variant Tyr955Cys. Treatment was initiated accordingly.", "spans": [{"start": 47, "end": 92, "label": "HPO_term"}, {"start": 121, "end": 142, "label": "HPO_term"}]}
{"text": "Upon examination, clinical signs of episodic decreased activity of mitochondrial complex iv, presence of intermittent bradykinesia were noted. Further imaging and laboratory tests identified gene variant R853W and G737R. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 45, "end": 91, "label": "HPO_term"}, {"start": 118, "end": 130, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with mild increased csf lactate observed. Diagnostic workup revealed gene variant 1399G\u2192A (A467T). Treatment was initiated accordingly.", "spans": [{"start": 46, "end": 67, "label": "HPO_term"}]}
{"text": "Upon examination, mild abnormal diffusion weighted cerebral mri morphology condition, chronic elevated circulating aspartate aminotransferase concentration manifestation, history of severe depletion of mitochondrial dna in muscle tissue, episodic increased csf lactate were noted. Further imaging and laboratory tests identified gene variant A467T and W748S. The patient was started on a tailored therapeutic plan.", "spans": [{"start": 23, "end": 74, "label": "HPO_term"}, {"start": 94, "end": 155, "label": "HPO_term"}, {"start": 189, "end": 236, "label": "HPO_term"}, {"start": 247, "end": 268, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with moderate elevated circulating alanine aminotransferase concentration condition, episodic multiple mitochondrial dna deletions symptoms, clinical signs of episodic increased csf lactate. Diagnostic workup revealed gene variant C752T (T251I) and C1760T (P587L). Treatment was initiated accordingly.", "spans": [{"start": 50, "end": 109, "label": "HPO_term"}, {"start": 130, "end": 166, "label": "HPO_term"}, {"start": 204, "end": 225, "label": "HPO_term"}]}
{"text": "A medical history of sudden elevated circulating aspartate aminotransferase concentration condition, sudden elevated circulating alanine aminotransferase concentration observed, severe abnormal diffusion weighted cerebral mri morphology, episodic multiple mitochondrial dna deletions manifestation was documented. Genetic analysis confirmed gene variant c.1288A>T and c.2752T>C. Supportive care and follow-up were recommended.", "spans": [{"start": 28, "end": 89, "label": "HPO_term"}, {"start": 108, "end": 167, "label": "HPO_term"}, {"start": 185, "end": 236, "label": "HPO_term"}, {"start": 247, "end": 283, "label": "HPO_term"}]}
{"text": "A medical history of chronic elevated circulating alanine aminotransferase concentration, acute abnormal cerebral cortex morphology detected, acute multiple mitochondrial dna deletions detected was documented. Genetic analysis confirmed gene variant c.1156C>T p.R386C and c.2794C>T p.H932Y. Supportive care and follow-up were recommended.", "spans": [{"start": 29, "end": 88, "label": "HPO_term"}, {"start": 96, "end": 131, "label": "HPO_term"}, {"start": 148, "end": 184, "label": "HPO_term"}]}
{"text": "Initial symptoms included mild multiple mitochondrial dna deletions detected, chronic bradykinesia manifestation, intermittent decreased activity of mitochondrial complex i symptoms, presence of severe elevated circulating alanine aminotransferase concentration. Subsequent investigations showed gene variant c.752C>T p.T251I and c.1760C>T p.P587L. Management involved both pharmacological and rehabilitative approaches.", "spans": [{"start": 31, "end": 67, "label": "HPO_term"}, {"start": 86, "end": 98, "label": "HPO_term"}, {"start": 127, "end": 172, "label": "HPO_term"}, {"start": 202, "end": 261, "label": "HPO_term"}]}
{"text": "The patient presented to the clinic with clinical signs of chronic decreased activity of mitochondrial complex iv, episodic depletion of mitochondrial dna in muscle tissue observed. Diagnostic workup revealed gene variant A467T and W748S. Treatment was initiated accordingly.", "spans": [{"start": 67, "end": 113, "label": "HPO_term"}, {"start": 124, "end": 171, "label": "HPO_term"}]}
